title: Unusual presentation of PRES in the postnatal period.
abstract: Posterior reversible encephalopathy syndrome (PRES) is a clinicoradiological entity, associated with a vast array of medical conditions and a variety of presenting symptoms. There is a characteristic pattern of radiographic features alongside suggestive clinical manifestations, which lead to a diagnosis of PRES. This report describes the case of a 39 years old, previously normotensive woman, who presented on day 7 postpartum with generalised tonic clonic seizures, reduced conscious level and a history of blurred vision and headache. She was treated immediately as eclamptic and transferred to the intensive care unit for stabilisation. Following an inconclusive CT result, an MRI was performed 2 days after presentation, which demonstrated white matter changes consistent with those found in PRES. She made a full recovery and a repeat MRI scan 7 weeks later showed no progression of the lesions noted on the original scan.
authors.affiliation: Department of O&G, Conquest Hospital, St Leonards-on-Sea, UK.
authors.forename: Miriam
authors.initials: M
authors.lastname: O'Kane
authors.affiliation: Department of O&G, Conquest Hospital, St Leonards-on-Sea, UK.
authors.forename: Hosam
authors.initials: H
authors.lastname: Elhalwagy
authors.affiliation: Department of O&G, Conquest Hospital, St Leonards-on-Sea, UK.
authors.forename: Sathish
authors.initials: S
authors.lastname: Kumar
authors.affiliation: Department of O&G, Conquest Hospital, St Leonards-on-Sea, UK.
authors.forename: Claire
authors.initials: C
authors.lastname: Badawi
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D000959:Antihypertensive Agents / Q000008:administration & dosage*; D003422:Critical Care; D003937:Diagnosis, Differential; D005260:Female; D005440:Fluid Therapy; D005500:Follow-Up Studies; D006261:Headache / Q000209:etiology*; D006801:Humans; D007741:Labetalol / Q000008:administration & dosage*; D008278:Magnesium Sulfate / Q000008:administration & dosage*; D008279:Magnetic Resonance Imaging; D010397:Penicillanic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives; D010878:Piperacillin / Q000008:administration & dosage; D000077725:Piperacillin, Tazobactam Drug Combination; D054038:Posterior Leukoencephalopathy Syndrome / Q000175:diagnosis* / Q000628:therapy; D049590:Postpartum Period; D012640:Seizures / Q000209:etiology* / Q000628:therapy; D018805:Sepsis / Q000188:drug therapy; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D000959:Antihypertensive Agents; D000077725:Piperacillin, Tazobactam Drug Combination; D008278:Magnesium Sulfate; D010397:Penicillanic Acid; D007741:Labetalol; D010878:Piperacillin